1. Kabi Pharmacia will assay plasma terodiline concentrations

   Newsletter Article 29 January 2013 Pages: 1 - 1

2. Seizures may occur in imipenem recipients with impaired renal function

   Newsletter Article 29 January 2013 Pages: 1 - 1

3. Triazolam should be withdrawn

   Newsletter Article 29 January 2013 Pages: 2 - 2

4. Beware of anaphylaxis with phytomenadione …

   Newsletter Article 29 January 2013 Pages: 2 - 2

5. … and with iron dextran

   Newsletter Article 29 January 2013 Pages: 3 - 3

6. Greater awareness is needed to reduce the risks of vitamin supplements in infants

   Newsletter Article 29 January 2013 Pages: 3 - 3

7. Thrombopenia as a result of cramp prevention

   Newsletter Article 29 January 2013 Pages: 3 - 3

8. Drug interactions with antisecretory agents are examined

   Newsletter Article 29 January 2013 Pages: 3 - 4

9. ACE inhibitors

   Newsletter Article 29 January 2013 Pages: 4 - 4

10. Anistreplase

    Newsletter Article 29 January 2013 Pages: 4 - 5

11. Anistreplase/aspirin/heparin

    Newsletter Article 29 January 2013 Pages: 5 - 5

12. Anticonvulsants

    Newsletter Article 29 January 2013 Pages: 5 - 5

13. Antineoplastics

    Newsletter Article 29 January 2013 Pages: 5 - 5

14. Aspirin see Anistreplase/aspirin/heparin

    Newsletter Article 29 January 2013 Pages: 5 - 5

15. Azathioprine/prednisone

    Newsletter Article 29 January 2013 Pages: 5 - 5

16. Barium

    Newsletter Article 29 January 2013 Pages: 5 - 5

17. Bromocriptine

    Newsletter Article 29 January 2013 Pages: 5 - 6

18. Budesonide

    Newsletter Article 29 January 2013 Pages: 6 - 6

19. Busulfan/cyclophosphamide

    Newsletter Article 29 January 2013 Pages: 6 - 6

20. Carbamazepine

    Newsletter Article 29 January 2013 Pages: 6 - 6

21. Cefamandole

    Newsletter Article 29 January 2013 Pages: 6 - 6

22. Cisplatin

    Newsletter Article 29 January 2013 Pages: 6 - 6

23. Clonazepam

    Newsletter Article 29 January 2013 Pages: 6 - 6

24. Clozapine

    Newsletter Article 29 January 2013 Pages: 6 - 7

25. Cyclophosphamide see Busulfan/cyclophosphamide

    Newsletter Article 29 January 2013 Pages: 7 - 7

26. Cyclosporin see Granulocyte-macrophage colony-stimulating factor/cyclosporin

    Newsletter Article 29 January 2013 Pages: 7 - 7

27. Cyproheptadine see Fluoxetine interaction

    Newsletter Article 29 January 2013 Pages: 7 - 7

28. Cytarabine

    Newsletter Article 29 January 2013 Pages: 7 - 7

29. Danazol withdrawal

    Newsletter Article 29 January 2013 Pages: 7 - 7

30. Disease modifying antirheumatic drugs

    Newsletter Article 29 January 2013 Pages: 7 - 7

31. Eflornithine

    Newsletter Article 29 January 2013 Pages: 7 - 7

32. Epoetin interaction

    Newsletter Article 29 January 2013 Pages: 7 - 7

33. Floxuridine see Fluorouracil/floxuridine

    Newsletter Article 29 January 2013 Pages: 7 - 7

34. Fluconazole

    Newsletter Article 29 January 2013 Pages: 7 - 8

35. Fluorouracil/floxuridine

    Newsletter Article 29 January 2013 Pages: 8 - 8

36. Fluoxetine interaction

    Newsletter Article 29 January 2013 Pages: 8 - 8

37. Fluspirilene

    Newsletter Article 29 January 2013 Pages: 8 - 8

38. Granulocyte-macrophage colonystimulating factor/cyclosporin

    Newsletter Article 29 January 2013 Pages: 8 - 9

39. Heparin see Anistreplase/aspirin/heparin

    Newsletter Article 29 January 2013 Pages: 9 - 9

40. Hormone replacement therapy

    Newsletter Article 29 January 2013 Pages: 9 - 9

41. Indigotindisulfonate sodium

    Newsletter Article 29 January 2013 Pages: 9 - 9

42. Interferon alpha see Epoetin interaction

    Newsletter Article 29 January 2013 Pages: 9 - 9

43. Lithium overdose

    Newsletter Article 29 January 2013 Pages: 9 - 9

44. Medroxyprogesterone

    Newsletter Article 29 January 2013 Pages: 9 - 9

45. Mefloquine

    Newsletter Article 29 January 2013 Pages: 9 - 9

46. Methotrexate

    Newsletter Article 29 January 2013 Pages: 9 - 10

47. Mitomycin

    Newsletter Article 29 January 2013 Pages: 10 - 10

48. Naproxen

    Newsletter Article 29 January 2013 Pages: 10 - 10

49. Nifedipine

    Newsletter Article 29 January 2013 Pages: 10 - 10

50. NSAIDs

    Newsletter Article 29 January 2013 Pages: 10 - 10